Pivotal phase III trial of ciprofloxacin 0.3% otic foam (FoamOtic Externa) in patients with acute otitis externa.

Trial Profile

Pivotal phase III trial of ciprofloxacin 0.3% otic foam (FoamOtic Externa) in patients with acute otitis externa.

Planning
Phase of Trial: Phase III

Latest Information Update: 10 May 2017

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Otitis externa
  • Focus Registrational; Therapeutic Use
  • Sponsors Novus Therapeutics; Otic Pharma
  • Most Recent Events

    • 10 May 2017 According to Tokai Pharmaceuticals Media Release, Tokai Pharmaceuticals has merged with Otic Pharma and subsequently changed its name to Novus Therapeutics.
    • 22 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top